ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$3.97
+0.09 (+2.32%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+140.6% upside
Low Target
$5.95
Average Target
$9.55
High Target
$10.69
Current Price
$3.97
Current
$3.97
$3.97
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Scenario Analysis
Bear Case
$5.95
49.9%
Low target
Base Case
$9.55
+140.6%
Avg target
Bull Case
$10.69
+169.3%
High target
Risk/Reward
3.4x
Highly favorable
Price in Context
52-Week High
$5.01
-20.8% from high
52-Week Low
$1.98
+101.0% from low
Target vs 52W High
$9.55
+90.6% vs high
Next Earnings Report
Jul 15, 2026
20d
until earnings
EPS Est: $0.19
Peer Consensus — Pharmaceuticals